Condition
Hemangiopericytoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hemangiopericytoma clinical trials that are recruiting, at sites in 12 countries (most in Netherlands (2), Austria (1), Belgium (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 12Countries
All recruiting trials (2)
-
Observational assessment of treatment outcomes for patients with primary brain tumors
This study looks at how well treatments work for people with rare primary brain tumors using new classification guidelines to see if they help doctors group patients better.
-
Proton therapy for brain tumors
This study is testing whether proton therapy can be a better treatment option for patients with certain brain tumors by comparing it to traditional radiation methods to see if it can reduce harm to healthy tissues.
Related topics
Quick answers
How many Hemangiopericytoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in Netherlands (2 trials), Austria (1 trial), Belgium (1 trial), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.